Huntington's disease

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 15-24

  Anderson, Karen E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; GENETICS; HUMAN; HUNTINGTON CHOREA;

HUMANS; HUNTINGTON DISEASE;

EID: 79954459815     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00002-1     Document Type: Book

References (126)

1. Almqvist E.W., Bloch M., Brinkman R., et al. A worldwide assessment of the frequency of suicide, suicide attempts or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999, 64:1293-1304.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders (4th ed., text rev.) 1994, Washington, DC.
3. Anderson K.E., Marder K.M. Huntington's Disease. Current Therapy in Neurologic Disease 2002, 282-287. Mosby, Philadelphia, USA. 6th Edn. R.T. Johnson, J.W. Griffin, J.C. McArthur (Eds.).
4. Anderson K.E., Louis E.D., Stern Y., et al. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. Am J Psychiatry 2001, 158:799-801.
5. Aylward E.H., Li Q., Stine O.C., et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997, 48:394-399.
6. Aylward E.H., Anderson N.B., Bylsma F.W., et al. Frontal lobe volume in patients with Huntington's disease. Neurology 1998, 50:252-258.
7. Aylward E.H., Codori A.M., Rosenblatt A., et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 2000, 15:552-560.
8. Bäckman L., Robins-Wahlin T.B., Lundin A., et al. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 1997, 120(Pt 12):2207-2217.
9. Bartenstein P., Weindl A., Spiegel S., et al. Central motor processing in Huntington's disease. A PET study. Brain 1997, 120:1553-1567.
10. Baxter L.R., Mazziotta J.C., Pahl J.J., et al. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiatry 1992, 49:148-152.
11. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann Neurol 1992, 31:119-130.
12. Beglinger L.J., Langbehn D.R., Duff K., et al. Probability of obsessive and compulsive symptoms in Huntington's disease. Biol Psychiatry 2007, 61:415-418.
13. Beglinger L.J., Paulsen J.S., Watson D.B., et al. Obsessive and compulsive symptoms in prediagnosed Huntington's disease. J Clin Psychiatry 2008, 69:1758-1765.
14. Berent S., Giordani B., Lehtinen S., et al. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function. Ann Neurol 1988, 23:541-546.
15. Berrios G.E., Wagle A.C., Markova I.S., et al. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Res 2001, 102:217-225.
16. Berrios G.E., Wagle A.C., Markova I.S., et al. Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects. Acta Psychiatr Scand 2002, 105:224-230.
17. Biglan K.M., Ross C.A., Langbehn D.R., et al. Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study. Mov Disord 2009, 24(12):1763-1772.
18. Boll T.J., Heaton R., Reitan R. Neuropsychological and emotional correlates of Huntington's disease. Journal of Mental and Nervous Disorders 1974, 158:61-69.
19. Bombard Y., Veenstra G., Friedman J.M., et al. Canadian Respond-HD Collaborative Group. Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey. BMJ 2009, 338:b2175.
20. Bonelli R.M., Hofmann P. A review of the treatment options for Huntington's disease. Expert Opin Pharmacother 2004, 5(4):767-776.
21. Brandt J. Cognitive impairments in Huntington's disease: insights into the neuropsychology of the striatum. Handbook of Neuropsychology 1991, Vol. 5. Elsevier, Amsterdam.
22. Brandt J., Strauss M.E., Larus J., et al. Clinical correlates of dementia and disability in Huntington's disease. J Clin Neuropsychol 1984, 6:401-412.
23. Brothers C.R.D., Meadows A.W. An investigation of Huntington's chorea in Victoria. J Ment Sci 1955, 101:548-563.
24. Butters N. The clinical aspects of memory disorders: contributions from experimental studies of amnesia and dementia. J Clin Neuropsychol 1984, 6:17-36.
25. Butters N., Albert M.S. Processes underlying failures to recall remote events. Human, Memory, and Amnesia 1982, 257-274. Erlbaum, Hillsdale, NJ. L.S. Cermak (Ed.).
26. Butters N., Wolfe J., Granholm E., et al. An assessment of verbal recall, recognition, and fluency abilities in patients with Huntington's disease. Cortex 1986, 22:11-32.
27. Butters N., Salmon D.P., Cullum C.M., et al. Differentiation of amnesic and demented patients with the Wechsler Memory Scale-Revised. Clin Neuropsychol 1988, 2:133-148.
28. Caine E.D., Shoulson I. Psychiatric syndromes in Huntington's disease. Am J Psychiatry 1983, 140:728-733.
29. Caserta M.T., Sullivan E. Late-onset Huntington's disease masquerading as normal pressure hydrocephalus. J Neuropsychiatry Clin Neurosci 2009, 21:97-98.
30. Chatterjee A., Anderson K.E., Moskowitz C.B., et al. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. J Neuropsychiatry Clin Neurosci 2005, 17:378-383.
31. Codori A.M., Slavney P.R., Rosenblatt A., et al. Prevalence of major depression one year after predictive testing for Huntington's disease. Genet Test 2004, 8:114-119.
32. Corrêa B.B., Xavier M., Guimarães J. Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree. Clin Pract Epidemol Ment Health 2006, 2:1.
33. Craufurd D., Thompson J.C., Snowden J.S. Behavioural changes in Huntington's disease. Neuropsychiatry Neuropsychol Behav Neurol 2001, 14:219-226.
34. Delis D.C., Massman P.J., Butters N., et al. Profiles of demented and amnesic patients on the California Verbal Learning Test: implications for the assessment of memory disorders. Psychological Assessment: A Journal of Consulting and Clinical Psychology 1991, 3:19-26.
35. Dewhurst K., Oliver J., Trick K.L.K., et al. Neuro-psychiatric aspects of Huntington's disease. Confin Neurol 1969, 31:258-268.
36. Difiglia M. Excitotoxic injury of the neostriatum is a model for Huntington's disease. Trends Neurosci 1990, 13:286-289.
37. Duff K., Paulsen J.S., Beglinger L.J., et al. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry 2007, 62:1341-1346.
38. Farrer L.A. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet 1986, 24:305-311.
39. Folstein S.E. Huntington Disease: A Disorder of Families 1989, The Johns Hopkins Press, Baltimore.
40. Folstein S.E., Chase G.A., Wahl W.E., et al. Huntington's disease in Maryland: clinical aspects of racial variation. Am J Hum Genet 1987, 41:168-179.
41. Gilstad J., Reich S.G. Chorea in an octogenarian. Neurologist 2003, 9:165-166.
42. Gontkovsky S.T. Huntington's disease: a neuropsychological overview. J Cogn Rehab 1998, 16:6-9.
43. Hamilton J.M. Cognitive, motor, and behavioral correlates of functional decline in Huntington's disease 1998, Clinical Psychology. University of California, San Diego, p. 58.
44. Hanes K.R., Andrewes D.G., Pantelis C. Cognitive flexibility and complex integration in Parkinson's disease, Huntington's disease, and schizophrenia. J Int Neuropsychol Soc 1995, 1:545-553.
45. Harris G.J., Pearlson G.D., Peyser C.E., et al. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol 1992, 31:69-75.
46. Hayden M.R., MacGregor J.M., Beighton P.H. The prevalence of Huntington's chorea in South Africa. S Afr Med J 1980, 2:193-196.
47. Heathfield K.W. Huntington's chorea. Investigation into the prevalence of this disease in the area covered by the North East Metropolitan Regional Hospital Board. Brain 1967, 90:203-232.
48. Hedreen J.C., Peyser C.E., Folstein S.E., Ross C.A. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett. 1991, 133(2):257-261.
49. Hersch S.M., Rosas H.D. Neuroprotection for Huntington's disease: ready, set, slow. Neurotherapeutics 2008, 5:226-236.
50. Hodges J.R., Salmon D.P., Butters N. Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: A controlled prospective study. J Neurol Neurosurg Psychiatry 1990, 53:1089-1095.
51. Huntington Study Group Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 2006, 66:366-372.
52. Huntington Study Group TREND-HD Investigators Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol 2008, 65:1582-1589.
53. Jason G.W., Suchowersky O., Pajurkova E.M., et al. Cognitive manifestations of Huntington's disease in relation to genetic structure and clinical onset. Arch Neurol 1997, 54:1081-1088.
54. Josiassen R.C., Curry L.M., Mancall E.L. Development of neuropsychological deficits in Huntington's disease. Arch Neurol 1983, 40:791-796.
55. Kagel M.C., Leopold N.A. Dysphagia in Huntington's disease: a 16-year retrospective. Dysphagia 1992, 7(2):106-114.
56. Kirkwood S.C., Siemers E., Viken R., et al. Longitudinal personality changes among presymptomatic Huntington disease gene carriers. Neuropsychiatry Neuropsychol Behav Neurol 2002, 15:192-197.
57. Klempír J., Klempírová O., Stochl J., Spacková N., et al. The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease. J Neurol. 2009, 256(10):1629-1633.
58. Kramer J.H., Delis D.C., Blusewicz M.J., et al. Verbal memory errors in Alzheimer's and Huntington's dementias. Dev Neuropsychol 1988, 4:1-15.
59. Kuhl D.E., Phelps M.E., Markham C.H., et al. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol 1982, 12:425-434.
60. Langbehn D.R., Paulsen J.S. Huntington Study Group. Predictors of diagnosis in Huntington disease. Neurology 2007, 68:1710-1717.
61. Lang C.J.G., Majer M., Balan P. Recall and recognition in Huntington's disease. Arch Clin Neuropsychology 2000, 15:361-371.
62. Lange K.W., Sahakian B.J., Quinn N.P., et al. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of demetia. J Neurol Neurosurg Psychiatry 1995, 58:598-606.
63. Lanska D.J., Lanska M.J., Lavine L., Schoenberg B.S. Conditions associated with Huntington's disease at death. A case-control study. Arch Neurol. 1988, 45(8):878-880.
64. Lawrence A.D., Sahakian B.J., Hodges J.R., et al. Executive and mnemonic functions in early Huntington's disease. Brain 1996, 119:1633-1645.
65. Leroi I., Michalon M. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature. Can J Psychiatry 1998, 43:933-940.
66. Levy M.L., Cummings J.L., Fairbanks L.A., et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998, 10:314-319.
67. Lishman A.W. Senile dementias, presenile dementias, and pseudodementias. Organic Psychiatry: The Psychological Consequences of Cerebral Disorder 1998, 468-469. Blackwell Science, Oxford. A.W. Lishman (Ed.).
68. Marder K., Zhao H., Myers R.H., et al. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 2000, 54:452-458.
69. Massman P.J., Delis D.C., Butters N., et al. Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J Clin Exp Neuropsychol 1990, 12:729-744.
70. Mestre T., Ferreira J., Coelho M.M. Therapeutic interventions for disease progression in Huntington's disease. Cochrane Database Syst Rev 2009, 8(3). CD006455.
71. Mickes L., Kane A., Jacobson M., et al. A comparison of two brief cognitive screening instruments in Huntington Disease (HD). Neurotherapeutics 2008, 5:37-373.
72. Middleton F.A., Strick P.L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 2000, 31:236-250.
73. Mohr E., Brouwers P., Claus J.J., et al. Visuospatial cognition in Huntington's disease. Mov Disord 1991, 6:127-132.
74. Moskowitz C.B., Marder K. Palliative care for people with late-stage Huntington's disease. Neurol Clin 2001, 19:849-865.
75. Murgod U.A., Saleem Q., Anand A., et al. A clinical study of patients with genetically confirmed Huntington's disease from India. J Neurol Sci 2001, 190:73-78.
76. Nahhas F., Garbern J., Feely S., et al. An intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling. Am J Med Genet A 2009, 149A:732-736.
77. Nance M.A., Sanders G. Characteristics of individuals with Huntington disease in long-term care. Mov Disord 1996, 11:542-548.
78. Nasreddine Z.S., Phillips N.A., Bédirian V., et al. The Montreal Cognitive Assessment, moca: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699.
79. Nucifora F.C., Sasaki M., Peters M.F., et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 2001, 291:2423-2428.
80. Oliver J.E. Huntington's chorea in Northamptonshire. Br J Psychiatry 1970, 116:241-253.
81. Paulsen J.S., Butters N., Salmon D.P., et al. Prism adaptation in Alzheimer's and Huntington's disease. Neuropsychology 1993, 7:73-81.
82. Paulsen J.S., Butters N., Sadek J.R., et al. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology 1995, 45:951-956.
83. Paulsen J.S., Stout J.C., Delapena J., et al. Frontal behavioral syndromes in cortical and subcortical dementia. Assessment 1996, 3:327-337.
84. Paulsen J.S., Como P., Rey G., et al. The clinical utility of the Stroop test in a multicenter study of Huntington's disease. J Int Neuropsychol Soc 1996, 2:35.
85. Paulsen J.S., Ready R.E., Hamilton J.M., et al. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psych 2001, 71:310-314.
86. Paulsen J.S., Nehl C., Hoth K.F., et al. Depression and stages of Huntington's disease. J Neuropsychiatry Clin Neurosci 2005, 17:496-502.
87. Paulsen J.S., Hoth K.F., Nehl C., et al. Critical periods of suicide risk in Huntington's disease. Am J Psychiatry 2005, 162:725-731.
88. Pavese N., Andrews T.C., Brooks D.J., et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain 2003, 126:1127-1135.
89. Pflanz S., Besson J.A.O., Ebmeier K.P., et al. The clinical manifestation of mental disorder in Huntington's disease: a retrospective case record study of disease progression. Acta Psychiatr Scand 1991, 83:53-60.
90. Pillon B., Dubois B., Ploska A., et al. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991, 41:634-643.
91. Potegal M. A note on spatial motor deficits in patients with Huntington's disease: a test of a hypothesis. Neuropsychologia 1971, 9:233-235.
92. Reuter I., Hu M.T., Andrews T.C., et al. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry. 2000, 68(2):238-241.
93. Ribaï P., Nguyen K., Hahn-Barma V., et al. Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients. Arch Neurol 2007, 64:813-819.
94. Robins Wahlin T.B., Bäckman L., Lundin A., et al. High suicidal ideation in persons testing for Huntington's disease. Acta Neurol Scand 2000, 102:150-161.
95. Rosas H.D., Goodman J., Chen Y.I., et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology 2001, 25:1025-1028.
96. Rosas H.D., Liu A.K., Hersch S., et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002, 58:695-701.
97. Rosas H.D., Koroshetz W.J., Chen Y.I., et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003, 27:1615-1620.
98. Rosas H.D., Salat D.H., Lee S.Y., et al. Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?. Ann N Y Acad Sci 2008, 1147:196-205.
99. Rosenblatt A., Ranen N.G., Nance M.A., et al. A physician's guide to the management of Huntington's disease: Huntington's Disease Society of America 1999, New York.
100. Rothlind J.C., Brandt J. A brief assessment of frontal and subcortical functions in dementia. J Neuropsychiatry Clin Neurosci 1993, 5:73-77.
101. Savage C.R. Neuropsychology of subcortical dementias. Psychiatr Clin North Am 1997, 20:911-931.
102. Schoenfeld M., Myers R.H., Cupples L.A., et al. Increased rate of suicide among patients with Huntington's disease. J Neuro Neurosurg Psychiatry 1984, 47:1283-1287.
103. Scourfield J., Soldan J., Gray J., et al. Huntington's disease: psychiatric practice in molecular genetic prediction and diagnosis. Br J Psychiatry 1997, 170:146-149.
104. Snowden J.S., Craufurd D., Thompson J., et al. Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol 2002, 24:133-145.
105. Snowden J.S., Gibbons Z.C., Blackshaw A., et al. Social cognition in frontotemporal dementia and Huntington's disease. Neuropsychologia 2003, 41:688-701.
106. Sprengelmeyer R., Lange H., Homberg V. The pattern of attentional deficits in Huntington's disease. Brain 1995, 118:145-152.
107. Stout J.C., Rodawalt W.C., Siemers E.R. Risky decision making in Huntington's disease. J Int Neuropsychol Soc 2001, 7:92-101.
108. Strauss M.E., Brandt J. An attempt at presymptomatic identification of Huntington's disease with the WAIS. J Clin Exp Neuropsychol 1986, 8:210-228.
109. Strong T.V., Tagle D.A., Valdes J.M., et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet 1993, 5:259-265.
110. Thompson J.C., Snowden J.S., Craufurd D., et al. Behavior in Huntington's disease: Dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci 2002, 14:37-43.
111. Thompson J.C., Poliakoff E., Sollom A.C., et al. Automaticity and attention in Huntington's disease: when two hands are not better than one. Neuropsychologia 2010, 48(1):171-178.
112. Trejo A., Tarrats R.M., Alonso M.E., et al. Nutrition 2004, 20(2):192-196.
113. Tsuang D., DiGiacomo L., Lipe H., et al. Familial aggregation of schizophrenia-like symptoms in Huntington's disease. Am J Med Genet 1998, 81:323-327.
114. van Duijn E., Kingma E.M., van der Mast R.C. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007, 19:441-448.
115. Vassos E., Panas M., Kladi A., et al. Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease. Biol Psychiatry 2007, 62:1347-1352.
116. Vassos E., Panas M., Kladi A., et al. Effect of CAG repeat length on psychiatric disorders in Huntington's disease. J Psychiatr Res 2008, 42:544-549.
117. Vonsattel J.P., Difiglia M. Huntington's disease. J Neuropathol Exp Neurol 1998, 57:369-384.
118. Vonsattel J.P., Myers R.H., Stevens T.J., et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985, 44(6):559-577.
119. Watkins L.H., Rogers R.D., Lawrence A.D., et al. Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia 2000, 38:1112-1125.
120. Weaver K.E., Richards T.L., Liang O., et al. Longitudinal diffusion tensor imaging in Huntington's disease. Exp Neurol 2009, 216(2):525-529.
121. Weingartner H., Caine E.D., Ebert M.H., et al. Imagery, encoding, and retrieval of information from memory: some specific encoding-retrieval changes in Huntington's disease. J Abnorm Psychol 1979, 88:52-58.
122. Wheeler V.C., Persichetti F., McNeil S.M., et al. US-Venezuela Collaborative Research Group. Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet 2007, 44(11):695-701.
123. Wheelock V.L., Tempkin T., Marder K., et al. Predictors of nursing home placement in Huntington disease. Neurology 2003, 60:998-1001.
124. Willingham D.B., Koroshetz W.J., Peterson E.W. Motor skills have diverse neural bases: spared and impaired skill acquisition in Huntington's disease. Neuropsychology 1996, 10:315-321.
125. Young A.B., Penney J.B., Starosta-Rubinstein S., et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986, 20:296-303.
126. Zappacosta B., Monza D., Meoni C., et al. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Arch Neurol 1996, 53:493-497.